Home>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Tiamulin fumarate (Thiamutilin fumarate)

Tiamulin fumarate (Thiamutilin fumarate) (Synonyms: 81723 Hfu, SQ 22,947)

Catalog No.GC32091

Tiamulin fumarate (Thiamutilin fumarate) (Thiamutilin fumarate) is a diterpenic compound that widely used in swine for the control of infectious diseases, including swine dysentery and enzootic pneumonia.

Products are for research use only. Not for human use. We do not sell to patients.

Tiamulin fumarate (Thiamutilin fumarate) Chemical Structure

Cas No.: 55297-96-6

Size Price Stock Qty
10mM (in 1mL DMSO)
$50.00
In stock
250mg
$46.00
In stock
1g
$92.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tiamulin is a diterpenic veterinary drug widely used in swine for the control of infectious diseases, including swine dysentery and enzootic pneumonia.

[1]. Noa M, et al. Tiamulin-nitrovin interaction in pigs: a case report and experimental reproduction. Vet Hum Toxicol. 2000 Oct;42(5):286-8. [2]. Dreyfuss J, et al. Metabolism of tritium- and carbon-14-labeled tiamulin in dogs, rats, and pigs. J Antibiot (Tokyo). 1979 May;32(5):496-503. [3]. Islam KM, et al. The activity and compatibility of the antibiotic tiamulin with other drugs in poultry medicine--A review. Poult Sci. 2009 Nov;88(11):2353-9.

Reviews

Review for Tiamulin fumarate (Thiamutilin fumarate)

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tiamulin fumarate (Thiamutilin fumarate)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.